reclassify Marinol (dronabinol) from Schedule II to Schedule III

The DEA is proposing to reclassify Marinol (dronabinol) from Schedule II to Schedule III.

Marinol is a synthetic form of THC...the active ingredient in marijuana. It's used for nausea or to improve appetite in patients with cancer or AIDS.

Marinol has a low potential for abuse. Its slow onset doesn't produce the same high that people get from smoking marijuana.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote